These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1158904)

  • 1. Bacteriophage contamination in live poliovirus vaccine.
    Milch H; Fornosi F
    J Biol Stand; 1975; 3(3):307-10. PubMed ID: 1158904
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tests for the presence of bacteriophages in live virus vaccine].
    Albrycht H; Wysokińska T; Sporzyńska Z; Rymkiewicz D; Banach W
    Med Dosw Mikrobiol; 1981; 33(2):97-103. PubMed ID: 6272037
    [No Abstract]   [Full Text] [Related]  

  • 3. Bacteriophages and endotoxin in licensed live-virus vaccines.
    Moody EE; Trousdale MD; Jorgensen JH; Shelokov A
    J Infect Dis; 1975 May; 131(5):588-91. PubMed ID: 805187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of PCR for detection of mycoplasma DNA and pestivirus RNA in human live viral vaccines.
    Sasaki T; Harasawa R; Shintani M; Fujiwara H; Sasaki Y; Horino A; Kenri T; Asada K; Kato I; Chino F
    Biologicals; 1996 Dec; 24(4):371-5. PubMed ID: 9088554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines produced in diploid cell lines.
    Ikić D
    Natl Cancer Inst Monogr; 1968 Dec; 29():485-93. PubMed ID: 4976866
    [No Abstract]   [Full Text] [Related]  

  • 6. Monitoring vaccines for human oncogenicity.
    Miller RW
    Natl Cancer Inst Monogr; 1968 Dec; 29():453-5. PubMed ID: 4305436
    [No Abstract]   [Full Text] [Related]  

  • 7. The value of potency testing of poliomyelitis and measles vaccines as an integral part of cold chain surveillance.
    Saraswathy TS; Sinniah M; Lee WS; Lee PC
    Southeast Asian J Trop Med Public Health; 1993 Jun; 24(2):265-8. PubMed ID: 8266228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pattern of plaquing efficiency at different temperatures (PPET) as a differentiation tool among poliovirus type 3 Leon 12a1b progenies and its possible use as a genetic marker.
    Yoshii K; Matsukura T; Nakano M; Tagaya I
    J Biol Stand; 1979 Jul; 7(3):169-78. PubMed ID: 227907
    [No Abstract]   [Full Text] [Related]  

  • 9. No evidence for the contamination of live oral poliomyelitis vaccines with simian immunodeficiency virus.
    Ohta Y; Tsujimoto H; Ishikawa K; Yamamoto H; Doi Y; Honjo S; Arita M; Hayami M
    AIDS; 1989 Mar; 3(3):183-5. PubMed ID: 2540773
    [No Abstract]   [Full Text] [Related]  

  • 10. Bacteriophage contamination in calf sera collected by different methods from various sources.
    Vieu JF; Horodniceanu F; Klein B; Lehérissey M
    J Biol Stand; 1978 Oct; 6(4):261-6. PubMed ID: 755822
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaccine-related issues.
    Rev Infect Dis; 1982; 4(5):972-7. PubMed ID: 7146734
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical experience with vaccines produced in the human diploid cell line WI-38.
    Andzaparidze OG
    Natl Cancer Inst Monogr; 1968 Dec; 29():477-84. PubMed ID: 4976367
    [No Abstract]   [Full Text] [Related]  

  • 13. CURRENT STATUS OF MEASLES AND ORAL POLIOVIRUS VACCINES.
    MACLEOD DR
    Can Med Assoc J; 1964 Nov; 91(21):1118-22. PubMed ID: 14229761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of measles infection and of vaccination with certain live vaccines upon humoral immunity to smallpox.
    Marennikova SS; Askerov VF
    Bull World Health Organ; 1968; 39(2):299-306. PubMed ID: 5303411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of animals in the development and control of viral vaccines.
    Minor PD
    Dev Biol Stand; 1996; 86():113-20. PubMed ID: 8785940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and control of live oral poliovirus vaccine in WI-38 human diploid cells.
    Stones PB
    Dev Biol Stand; 1976 Dec 13-15; 37():251-3. PubMed ID: 1036401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary attempts to detect interactions between coliphages and two attenuated vaccine viruses.
    Petricciani JC; Meyer BC; Vallancourt RJ; Duryea WJ
    J Biol Stand; 1975; 3(4):335-40. PubMed ID: 810489
    [No Abstract]   [Full Text] [Related]  

  • 18. MEASLES AND POLIOMYELITIS VACCINES.
    KRUGMAN S
    N Y State J Med; 1963 Oct; 63():2973-7. PubMed ID: 14048473
    [No Abstract]   [Full Text] [Related]  

  • 19. Ethical and safety considerations for the use in clinical trials of new attenuated poliovirus strains.
    Horaud F
    Dev Biol Stand; 1993; 78():149-54; discussion 154-5. PubMed ID: 8388825
    [No Abstract]   [Full Text] [Related]  

  • 20. Feasible improvements in vaccines in the Expanded Programme on Immunization.
    McIntosh K
    Rev Infect Dis; 1989; 11 Suppl 3():S530-7. PubMed ID: 2669097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.